MARVEL BIOTECHNOLOGY
MARVEL BIOTECHNOLOGY
Social Links:
Industry:
Biotechnology Health Care
Address:
Calgary, Alberta, Canada
Country:
Canada
Website Url:
http://www.marvelbiotechnology.com
Status:
Active
Total Funding:
720 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Mobile Non Scaleable Content Nginx
Current Employees Featured
Stock Details
Official Site Inspections
http://www.marvelbiotechnology.com
- Host name: rachelweb.whc.ca
- IP address: 192.95.37.238
- Location: Montreal Canada
- Latitude: 45.5063
- Longitude: -73.5794
- Timezone: America/Toronto
- Postal: H3A
More informations about "Marvel Biotechnology"
About - Marvel Biosciences
(403) 770-2469 [email protected]. About Us; Technology. MB-204; Non-Hallucinogenic Neuroplasticity Program; News; Investors; Contact Us; Select Page. About …See details»
Index | Marvel Biosciences
Mar 17, 2025 (403) 770-2469 [email protected]. About Us; Technology. MB-204; Non-Hallucinogenic Neuroplasticity Program; News; …See details»
Marvel Biotechnology - Crunchbase Company Profile
Marvel Biotechnology is a life sciences company. Marvel Biotechnology is a biotech company that provides discovery and the development of a synthetic …See details»
Management Team - Marvel Biosciences
Experienced Management Team Marvel Biotechnology Inc. is at the forefront of modern pharmaceutical re-purposing technology. Lead by the dynamic team of Rod Matheson and …See details»
Marvel Biosciences Corp. | LinkedIn
Marvel Biosciences Corp. | 691 followers on LinkedIn. Leaders in biotech de-risking the (re)development of compounds for Alzheimer’s, Autism, Rett's & Fragile X Syndromes. | …See details»
Marvel Biosciences Corp. Overview | SignalHire Company Profile
Organization Website: marvelbiotechnology.com : Social Links: Phone Number (403) 770-2469: Marvel Biosciences C... industries Biotech: Headquarters Location: 117 8 Ave SW, Calgary, …See details»
Marvel Biosciences Corp. - Drug pipelines, Patents, Clinical
Explore Marvel Biosciences Corp. with its drug pipeline, therapeutic area, technology platform, 39 news, Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases, …See details»
Marvel Biosciences - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
MBCOF - MARVEL BIOSCIENCES CORP. | Company Profile | OTC …
4 days ago marvelbiotechnology.com +1 16045055231. [email protected]. Business Description. Marvel Biosciences Corp is a life sciences company focused on the …See details»
Marvel Biotechnology, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.marvelbiotechnology.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. ... The statistics for drugs in the …See details»
news - Marvel Biosciences
Nov 26, 2024 (403) 770-2469 [email protected]. About Us; Technology. MB-204; Non-Hallucinogenic Neuroplasticity Program; News; Investors; Contact Us; Select Page. …See details»
Marvel Biosciences Company Description - Stock Analysis
Company profile for Marvel Biosciences Corp. (TSXV: MRVL) with a description, list of executives, contact details and other key facts.See details»
Alphanco Venture Corp. Changes Name to Marvel Biosciences
Jul 8, 2021 Alphanco Venture Corp. (TSXV: AVC.P) (the "Company" or "AVC"), a capital pool company listed on the TSX Venture Exchange (the "TSXV"), is pleased to announce that it has …See details»
Company Marvel Biosciences Corp. - MarketScreener.com
Jun 13, 2021 Marvel Biosciences Corp.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Toronto S.E.: MRVL ...See details»
Corporate Presentation – April 2022 MRVL - TSXV - Marvel …
Www.marvelbiotechnology.com. Q2:2022. Complete Formulation studies. Begin MB -204 GLP toxicology studies. Q3:2022. Complete MB -204 GLP toxicology studies. Complete cGMP run …See details»
Marvel Biosciences Corp, MRVL:CVE profile - FT.com - Financial …
4 days ago Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical …See details»
Marvel Biosciences Announces New Program to Develop Novel …
Oct 27, 2021 Calgary, Alberta--(Newsfile Corp. - October 27, 2021) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the …See details»
Marvel Biosciences Provides Corporate Update as it Enters a …
Feb 8, 2022 Calgary, Alberta–(Newsfile Corp. – February 8, 2022) – Marvel Biosciences Corp. (TSXV: MRVL) and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the …See details»
Curing the incurable: Georgia Tech’s $40 million medical mission
3 days ago Georgia Tech stands on the brink of a medical revolution, fueled by a monumental award from the Marcus Foundation. This transformative $40 million endeavor, with a principal …See details»
Marvel Biosciences Announces Promising New Data from Rett …
Calgary, Alberta – November 26, 2024 – Marvel Biosciences Corp. (TSXV: MRVL OTC: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or …See details»